229 related articles for article (PubMed ID: 19068689)
1. [Case of androgenic anabolic steroid abuse caused hypogonadotropic hypogonadism].
Takayanagi A; Kobayashi K; Hashimoto K; Kato R; Masumori N; Itoh N; Tsukamoto T
Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):729-32. PubMed ID: 19068689
[TBL] [Abstract][Full Text] [Related]
2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
3. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
4. Anabolic steroid-induced hypogonadism: diagnosis and treatment.
Rahnema CD; Lipshultz LI; Crosnoe LE; Kovac JR; Kim ED
Fertil Steril; 2014 May; 101(5):1271-9. PubMed ID: 24636400
[TBL] [Abstract][Full Text] [Related]
5. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
7. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
[TBL] [Abstract][Full Text] [Related]
8. Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin.
Gill GV
Postgrad Med J; 1998 Jan; 74(867):45-6. PubMed ID: 9538490
[TBL] [Abstract][Full Text] [Related]
9. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
10. Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men.
Pope HG; Kanayama G
Endocrinol Metab Clin North Am; 2022 Mar; 51(1):205-216. PubMed ID: 35216717
[TBL] [Abstract][Full Text] [Related]
11. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
12. Anabolic steroid induced hypogonadism in young men.
Coward RM; Rajanahally S; Kovac JR; Smith RP; Pastuszak AW; Lipshultz LI
J Urol; 2013 Dec; 190(6):2200-5. PubMed ID: 23764075
[TBL] [Abstract][Full Text] [Related]
13. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
14. The Response to Gonadotropin-Releasing Hormone and hCG in Men with Prior Chronic Androgen Steroid Abuse and Clinical Hypogonadism.
Flanagan JN; Lehtihet M
Horm Metab Res; 2015 Aug; 47(9):668-73. PubMed ID: 25642745
[TBL] [Abstract][Full Text] [Related]
15. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
[TBL] [Abstract][Full Text] [Related]
16. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
17. Persistent primary hypogonadism associated with anabolic steroid abuse.
Boregowda K; Joels L; Stephens JW; Price DE
Fertil Steril; 2011 Jul; 96(1):e7-8. PubMed ID: 21575947
[TBL] [Abstract][Full Text] [Related]
18. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 34887237
[TBL] [Abstract][Full Text] [Related]
19. The deleterious effects of anabolic androgenic steroid abuse on sexual and reproductive health and comparison of recovery between treated and untreated patients: Single-center prospective randomized study.
Al Hashimi M
Andrologia; 2022 Dec; 54(11):e14576. PubMed ID: 36065528
[TBL] [Abstract][Full Text] [Related]
20. Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects.
Karavolos S; Reynolds M; Panagiotopoulou N; McEleny K; Scally M; Quinton R
Clin Endocrinol (Oxf); 2015 May; 82(5):624-32. PubMed ID: 25333666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
